Researchers Identify Gene Mutation That Raises Risk Of Nerve Damage in Leukaemia Patients Using Vincristine

Important research from St. Jude Children’s Research Hospital regarding the use of the anti-cancer drug Vincristine, often used for treating Acute Lymphoblastic Leukaemia (ALL)   Researchers from St. Jude Children’s Research Hospital have identified the first genetic variation that is associated with increased risk and severity of peripheral neuropathy following treatment with a widely used anti-cancer drug. Investigators also […]

Read more
Precision Medicine Study Reveals New Subtype of Childhood Leukaemia

New hope for Childhood Leukaemia? Research being done at UC San Francisco, MD Anderson Cancer Center and Oregon Health & Science University is very encouraging… A new study of acute lymphoblastic leukemia (ALL), a blood cancer that primarily affects young children, has revealed that the disease has two distinct subtypes, and provides preliminary evidence that about 13 percent […]

Read more